Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2025	Dec. 31, 2024
Current assets:
Cash and cash equivalents	$ 42,833	$ 52,670
Accounts receivable, net of allowances of $267 and $275	10,557	10,098
Inventory	13,533	12,781
Prepaid expenses and other current assets	2,822	2,522
Total current assets	69,745	78,071
Property and equipment, net	2,201	2,341
Intangible assets, net	1,644	1,739
Right-of-use assets	1,678	1,738
Other long-term assets	1,626	2,276
Deferred tax asset, net	92	140
Restricted cash	265	265
Total assets	77,251	86,570
Current liabilities:
Accounts payable	4,002	2,147
Accrued expenses and other current liabilities	12,534	13,451
Total current liabilities	16,536	15,598
Long-term debt	41,275	41,124
Other long-term liabilities	1,317	1,390
Total liabilities	59,128	58,112
Stockholders' equity:
Preferred stock; $0.001 par value: 10,000,000 shares authorized; no shares issued and outstanding
Common stock; $0.001 par value: 200,000,000 shares authorized; 39,554,771 and 39,395,712 shares issued and outstanding at March 31, 2025 and December 31, 2024, respectively	40	39
Additional paid-in capital	387,986	387,059
Accumulated other comprehensive income	91	90
Accumulated deficit	(369,994)	(358,730)
Total stockholders' equity	18,123	28,458
Total liabilities and stockholders' equity	$ 77,251	$ 86,570